Leaflet PLATIDIAM 10 0.5mg / ml concentrate for solution for infusion


Indicated for: cancer

Route of administration: infusion

Substance: cisplatin (antineoplastic agent)

ATC: L01XA01 (Antineoplastic and immunomodulating agents | Other antineoplastic agents | Platinum compounds)

Cisplatin is a chemotherapy medication used for the treatment of various types of cancer, including testicular, ovarian, bladder, and lung cancer. It works by binding to the DNA of tumor cells, inhibiting their replication and inducing cell death.

The medication is administered intravenously, as directed by a doctor, usually in a hospital or specialized clinic. It is important for patients to be monitored to prevent severe side effects.

Patients should be aware of potential side effects, such as nausea, vomiting, kidney dysfunction, or ototoxicity. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, vomiting, and fatigue. In rare cases, severe reactions such as kidney failure or hearing loss may occur. Patients should be informed of these risks before starting treatment.

General data about PLATIDIAM 10 0.5mg / ml

  • Substance: cisplatin
  • Date of last drug list: 01-07-2013
  • Commercial code: W08661002
  • Concentration: 0.5mg / ml
  • Pharmaceutical form: concentrate for solution for infusion
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Concentrations available for cisplatin

  • 0.5mg/ml
  • 10mg
  • 10mg/20ml
  • 1mg/1ml
  • 1mg/ml
  • 25mg/50ml
  • 50mg
  • 50mg/100ml